Clinical Trial Update: Changes in Insulin Resistance in Healthy Volunteers on STRIBILD® Medication [Phase 1]

View source ↗

Summary

A Phase 1 trial update on STRIBILD in healthy volunteers reports changes in insulin resistance. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance

Drugs mentioned

• Stribild (elvitegravir; cobicistat; emtricitabine; tenofovir disoproxil fumarate)

Snippet

Sponsor: Technical University of Munich | Conditions: Insulin Resistance | Phase 1 | Status: COMPLETED